United States · FDA National Drug Code directory
capecitabine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-496_25eb47d5-42ca-889b-6798-6f91d7795417
- Product NDC
- 55111-496
- Form
- TABLET
- Composition / generic term
- capecitabine
- Labeler
- Dr. Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20201210
- Source listing expiry
- 20271231
Source-listed ingredients
- CAPECITABINE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (55111-496-05) · 55111-496-05
- 60 TABLET in 1 BOTTLE (55111-496-60) · 55111-496-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →